Dana-Farber Cancer Institute — Clinical Trial Pipeline

Dana-Farber Cancer Institute has 12 registered trials in the index.

Trials (12)

Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia Phase 2 · Dana-Farber Cancer Institute
Improving Communication Between Cancer Patients & Oncologists N/A · Dana-Farber Cancer Institute
Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck Phase 1/2 · Dana-Farber Cancer Institute
Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy N/A · Dana-Farber Cancer Institute
Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer Phase 1 · Dana-Farber Cancer Institute
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) Phase 2 · Dana-Farber Cancer Institute
The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy) N/A · Dana-Farber Cancer Institute
The DISCOVER Study N/A · Dana-Farber Cancer Institute
Treatment of Childhood Acute Lymphoblastic Leukemia Phase 3 · Dana-Farber Cancer Institute
Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer N/A · Dana-Farber Cancer Institute
Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia Phase 2 · Dana-Farber Cancer Institute
Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia N/A · Dana-Farber Cancer Institute

Related landscapes

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.